2024 Q2 Form 10-K Financial Statement

#000149315224012503 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $1.777M $1.009M $6.125M
YoY Change 7.31% -50.9% -52.03%
Cost Of Revenue $1.482M $1.191M $5.966M
YoY Change -5.88% -40.07% -55.54%
Gross Profit $294.5K -$182.5K $158.1K
YoY Change 263.53% -372.47% -124.25%
Gross Profit Margin 16.58% -18.09% 2.58%
Selling, General & Admin $295.5K $559.7K $1.865M
YoY Change -36.72% 4.77% -9.58%
% of Gross Profit 100.32% 1179.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.377K $1.300K $4.521K
YoY Change -95.02% -99.14% -99.23%
% of Gross Profit 0.47% 2.86%
Operating Expenses $986.2K $1.283M $4.390M
YoY Change -14.78% -0.09% -14.98%
Operating Profit -$691.7K -$1.466M -$4.232M
YoY Change -35.73% 20.4% -63.56%
Interest Expense $871.2K $855.5K $1.772M
YoY Change 175.9% -208.98% 5.59%
% of Operating Profit
Other Income/Expense, Net $48.13K -$12.58K $12.71K
YoY Change 90.3% -114.75% -91.76%
Pretax Income -$1.842M -$622.7K -$4.472M
YoY Change 26.88% -91.06% -66.11%
Income Tax
% Of Pretax Income
Net Earnings -$1.842M -$622.7K -$4.472M
YoY Change 26.88% -91.06% -66.11%
Net Earnings / Revenue -103.68% -61.72% -73.01%
Basic Earnings Per Share -$1.52 -$0.88
Diluted Earnings Per Share -$1.52 -$0.05 -$0.88
COMMON SHARES
Basic Shares Outstanding 40.68M shares 14.45M shares 5.083M shares
Diluted Shares Outstanding 1.210M shares 5.083M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $73.11K $24.16K $24.16K
YoY Change 931.17% 160.91% 160.91%
Cash & Equivalents $73.11K $24.16K
Short-Term Investments
Other Short-Term Assets $2.455M $833.5K $833.5K
YoY Change 102.25% 24.04% 24.04%
Inventory $2.638M $2.609M $2.609M
Prepaid Expenses
Receivables $600.5K $534.2K $534.2K
Other Receivables $0.00 $95.52K $95.52K
Total Short-Term Assets $5.767M $4.096M $4.096M
YoY Change 18.87% -37.19% -37.19%
LONG-TERM ASSETS
Property, Plant & Equipment $359.0K $303.9K $428.9K
YoY Change 163.47% 152.37% 34.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $138.7K $102.2K $102.2K
YoY Change 10.57% -1.45% -1.45%
Total Long-Term Assets $2.338M $2.267M $2.267M
YoY Change 7.69% 5.07% 5.07%
TOTAL ASSETS
Total Short-Term Assets $5.767M $4.096M $4.096M
Total Long-Term Assets $2.338M $2.267M $2.267M
Total Assets $8.105M $6.362M $6.363M
YoY Change 15.42% -26.69% -26.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $839.5K $661.4K $661.4K
YoY Change -32.65% -72.46% -72.46%
Accrued Expenses $35.85K $35.43K $35.43K
YoY Change -31.92% -38.2% -38.2%
Deferred Revenue $47.82K
YoY Change 1.57%
Short-Term Debt $829.8K $156.9K $156.9K
YoY Change 61.21% 433.63% 433.63%
Long-Term Debt Due $144.0K $265.6K $265.6K
YoY Change -95.71% -92.28% -95.72%
Total Short-Term Liabilities $3.233M $3.197M $3.197M
YoY Change -50.69% -66.47% -66.47%
LONG-TERM LIABILITIES
Long-Term Debt $188.5K $481.3K $481.3K
YoY Change -47.95% 92.53% 92.53%
Other Long-Term Liabilities $68.94K $89.59K
YoY Change -8.08% -35.84%
Total Long-Term Liabilities $257.5K $0.00 $570.9K
YoY Change 243.27% -100.0% 46.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.233M $3.197M $3.197M
Total Long-Term Liabilities $257.5K $0.00 $570.9K
Total Liabilities $3.490M $3.768M $3.768M
YoY Change -50.41% -62.04% -62.04%
SHAREHOLDERS EQUITY
Retained Earnings -$36.75M -$33.81M
YoY Change 12.23% 15.24%
Common Stock $233.00 $2.324K
YoY Change -95.61% -14.05%
Preferred Stock
YoY Change
Treasury Stock (at cost) $76.32K $76.32K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $4.615M $2.595M $2.595M
YoY Change
Total Liabilities & Shareholders Equity $8.105M $6.362M $6.363M
YoY Change 15.42% -26.69% -26.69%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$1.842M -$622.7K -$4.472M
YoY Change 26.88% -91.06% -66.11%
Depreciation, Depletion And Amortization $1.377K $1.300K $4.521K
YoY Change -95.02% -99.14% -99.23%
Cash From Operating Activities -$1.959M -$418.5K -$3.531M
YoY Change 1077.11% -187.85% -2.44%
INVESTING ACTIVITIES
Capital Expenditures $34.60K $27.06K $159.6K
YoY Change -81.46% -46.22%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$34.60K -$27.06K -$159.6K
YoY Change -81.46% -77.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $76.32K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.027M 8.990K $3.676M
YoY Change 8930.96% -101.37% 19.54%
NET CHANGE
Cash From Operating Activities -1.959M -418.5K -$3.531M
Cash From Investing Activities -34.60K -27.06K -$159.6K
Cash From Financing Activities 2.027M 8.990K $3.676M
Net Change In Cash 33.67K -436.6K $14.90K
YoY Change -123.38% 33.58% -101.3%
FREE CASH FLOW
Cash From Operating Activities -$1.959M -$418.5K -$3.531M
Capital Expenditures $34.60K $27.06K $159.6K
Free Cash Flow -$1.994M -$445.6K -$3.690M
YoY Change 1097.9% -234.82% -5.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
usd
CY2023Q4 BSFC Current Maturities Of Longterm Debt Net Of Discounts
CurrentMaturitiesOfLongtermDebtNetOfDiscounts
usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2022Q4 BSFC Warrant Liabilities Current
WarrantLiabilitiesCurrent
usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
usd
CY2023 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
usd
CY2022 BSFC Allowance For Inventory Obsolescence
AllowanceForInventoryObsolescence
usd
CY2022 BSFC Loss On Settlement Of Debt
LossOnSettlementOfDebt
usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2022 BSFC Provision For Credit Losses
ProvisionForCreditLosses
usd
CY2022 BSFC Gain On Revaluation Of Fair Value Of Derivative And Warrant Liabilities
GainOnRevaluationOfFairValueOfDerivativeAndWarrantLiabilities
usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
CY2023 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2022 BSFC Proceeds From Common Stock Offering Prefunded Warrants
ProceedsFromCommonStockOfferingPrefundedWarrants
usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2022 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
usd
CY2022 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
CY2023 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
usd
CY2023 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
usd
CY2023 BSFC Warrants Issued For Convertible Debt
WarrantsIssuedForConvertibleDebt
usd
CY2023 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
usd
CY2022 BSFC Derivative Liability Recognized On Issuance Of Convertible Note
DerivativeLiabilityRecognizedOnIssuanceOfConvertibleNote
usd
CY2022 BSFC Warrant Liability Recognized On Issuance Of Convertible Note
WarrantLiabilityRecognizedOnIssuanceOfConvertibleNote
usd
CY2022 BSFC Common Stock Issued To Settle Loan From Stockholder
CommonStockIssuedToSettleLoanFromStockholder
usd
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
usd
CY2022Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
usd
CY2022Q4 BSFC Fair Value Net Warrant Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetWarrantAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
usd
CY2022 us-gaap Amount Of Dilutive Securities Esop Convertible Preferred Stock
AmountOfDilutiveSecuritiesESOPConvertiblePreferredStock
usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
usd
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021Q4 BSFC Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableIntrinsicValue1
usd
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 BSFC Deferred Tax Assets Business Interest Limitation
DeferredTaxAssetsBusinessInterestLimitation
usd
CY2022Q4 BSFC Deferred Tax Assets Allowance For Bad Debt
DeferredTaxAssetsAllowanceForBadDebt
usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
2199788 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40682568 shares
CY2023 dei Auditor Firm
AuditorFirmId
206
CY2023 dei Auditor Name
AuditorName
MaloneBailey, LLP
CY2023 dei Auditor Location
AuditorLocation
Houston, Texas
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24163 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9262 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
31064 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
22725 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
534195 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
813416 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2608521 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4808152 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
833472 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
671933 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
4095876 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
6521288 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
303857 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120400 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
125014 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
197540 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
102222 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
103720 usd
CY2023Q4 us-gaap Assets
Assets
6362498 usd
CY2022Q4 us-gaap Assets
Assets
8678477 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
661377 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2401243 usd
CY2023Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
189975 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1776068 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
47819 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
47078 usd
CY2022Q4 BSFC Current Maturities Of Longterm Debt Net Of Discounts
CurrentMaturitiesOfLongtermDebtNetOfDiscounts
3439557 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
35428 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57329 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
156938 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
29413 usd
CY2023Q4 BSFC Subordinated Notes Payable Related Party
SubordinatedNotesPayableRelatedParty
165620 usd
CY2022Q4 BSFC Subordinated Notes Payable Related Party
SubordinatedNotesPayableRelatedParty
893000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1047049 usd
CY2023Q4 BSFC Warrant Liabilities Current
WarrantLiabilitiesCurrent
1574 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
790881 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
790881 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3196661 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9534569 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
89586 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
139631 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
481329 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
250000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3767576 usd
CY2022Q4 us-gaap Liabilities
Liabilities
9924200 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23086077 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23086077 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1338321 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1338321 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2324 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
134 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
36659648 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28329116 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-179995 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-235853 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33810732 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29339120 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7564 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
76323 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2594922 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1245723 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6362498 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8678477 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6124529 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12767145 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
5966452 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
13419133 usd
CY2023 us-gaap Gross Profit
GrossProfit
158077 usd
CY2022 us-gaap Gross Profit
GrossProfit
-651988 usd
CY2023 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
2169 usd
CY2022 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
24482 usd
CY2023 us-gaap Salaries And Wages
SalariesAndWages
1858004 usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
2032457 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4521 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
584386 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5797906 usd
CY2023 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2525661 usd
CY2022 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2522764 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-4232278 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-11613983 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12708 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
154196 usd
CY2023 BSFC Loss On Debt Settlement
LossOnDebtSettlement
977188 usd
CY2022 BSFC Loss On Debt Settlement
LossOnDebtSettlement
57085 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2497088 usd
CY2023 us-gaap Interest Expense
InterestExpense
1771942 usd
CY2022 us-gaap Interest Expense
InterestExpense
1678097 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4471612 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13194969 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4471612 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13194969 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
55858 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-181613 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4415754 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13376582 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.88
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.88
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5082500 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5082500 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25158555 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25158555 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
8906968 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
187385 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1035253 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
667998 usd
CY2022 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
359250 usd
CY2022 BSFC Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
250000 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
547777 usd
CY2022 BSFC Common Stock Value Issued To Settle Related Party Notes Payable And Accrued Interest
CommonStockValueIssuedToSettleRelatedPartyNotesPayableAndAccruedInterest
176228 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13194969 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-181613 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1245723 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1245723 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
69125 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
477063 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3053088 usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3913446 usd
CY2023 BSFC Common Stock Issued To Settle Related Party Notes Payable
CommonStockIssuedToSettleRelatedPartyNotesPayable
250000 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
570000 usd
CY2023 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-76323 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4471612 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
55858 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2594922 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2594922 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4471612 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13194969 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
69125 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
187385 usd
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
319083 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
667998 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1244309 usd
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2679978 usd
CY2022 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
1873619 usd
CY2023 us-gaap Depreciation
Depreciation
4521 usd
CY2022 us-gaap Depreciation
Depreciation
231465 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
315420 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
868954 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1416120 usd
CY2023 BSFC Allowance For Inventory Obsolescence
AllowanceForInventoryObsolescence
176000 usd
CY2023 BSFC Loss On Settlement Of Debt
LossOnSettlementOfDebt
977188 usd
CY2023 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
72526 usd
CY2022 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
58723 usd
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
743218 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
405 usd
CY2023 BSFC Provision For Credit Losses
ProvisionForCreditLosses
8340 usd
CY2023 BSFC Gain On Revaluation Of Fair Value Of Derivative And Warrant Liabilities
GainOnRevaluationOfFairValueOfDerivativeAndWarrantLiabilities
2497088 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-270881 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-417360 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2023631 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3431929 usd
CY2023 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-123000 usd
CY2022 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
95759 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-140290 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-3030728 usd
CY2023 BSFC Increase Decrease In Right Of Use Liability
IncreaseDecreaseInRightOfUseLiability
71946 usd
CY2022 BSFC Increase Decrease In Right Of Use Liability
IncreaseDecreaseInRightOfUseLiability
58867 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-4467 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1922 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1737997 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
620167 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
189975 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-62336 usd
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-263768 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3530662 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3618811 usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
398482 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
159609 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
296793 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-159609 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-695275 usd
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1799506 usd
CY2023 BSFC Proceeds From Common Stock Offering Prefunded Warrants
ProceedsFromCommonStockOfferingPrefundedWarrants
4678924 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
250000 usd
CY2023 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
2405034 usd
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
12552008 usd
CY2023 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
700000 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1140000 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4762855 usd
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
4182971 usd
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
13144141 usd
CY2023 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
623000 usd
CY2023 BSFC Repayment Of Convertible Debt
RepaymentOfConvertibleDebt
2007435 usd
CY2022 BSFC Repayment Of Convertible Debt
RepaymentOfConvertibleDebt
1118888 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
157380 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
201434 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
76323 usd
CY2022 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
25000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3676355 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3075400 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28817 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
92435 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14901 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1146251 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9262 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1155513 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24163 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9262 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
923992 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
306045 usd
CY2023 BSFC Common Stock Issued To Settle Payable And Accrued Interest
CommonStockIssuedToSettlePayableAndAccruedInterest
250000 usd
CY2022 BSFC Common Stock Issued To Settle Payable And Accrued Interest
CommonStockIssuedToSettlePayableAndAccruedInterest
176228 usd
CY2022 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
185135 usd
CY2022 BSFC Warrants Issued For Convertible Debt
WarrantsIssuedForConvertibleDebt
1035253 usd
CY2022 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
359250 usd
CY2023 BSFC Common Stock Issued For Partial Settlement Of Note Payable
CommonStockIssuedForPartialSettlementOfNotePayable
3053088 usd
CY2022 BSFC Common Stock Issued For Partial Settlement Of Note Payable
CommonStockIssuedForPartialSettlementOfNotePayable
547777 usd
CY2023 BSFC Derivative Liability Recognized On Issuance Of Convertible Note
DerivativeLiabilityRecognizedOnIssuanceOfConvertibleNote
383672 usd
CY2023 BSFC Warrant Liability Recognized On Issuance Of Convertible Note
WarrantLiabilityRecognizedOnIssuanceOfConvertibleNote
453746 usd
CY2023 BSFC Common Stock Issued To Settle Loan From Stockholder
CommonStockIssuedToSettleLoanFromStockholder
570000 usd
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one-for-twenty reverse stock split
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
1244309 usd
CY2023 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 BSFC Sales Return And Allowances
SalesReturnAndAllowances
265700 usd
CY2022Q4 BSFC Sales Return And Allowances
SalesReturnAndAllowances
94000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
176000 usd
CY2023Q4 BSFC Inventory Purchased For Resale
InventoryPurchasedForResale
1708311 usd
CY2022Q4 BSFC Inventory Purchased For Resale
InventoryPurchasedForResale
3052518 usd
CY2023Q4 BSFC Inventory Feed Process
InventoryFeedProcess
102373 usd
CY2022Q4 BSFC Inventory Feed Process
InventoryFeedProcess
156984 usd
CY2023Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
973837 usd
CY2022Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
1598650 usd
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
176000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2608521 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4808152 usd
CY2023 BSFC Schedule Of Estimated Usefule Life Of Assets Table Text Bock
ScheduleOfEstimatedUsefuleLifeOfAssetsTableTextBock
<p id="xdx_89A_ecustom--ScheduleOfEstimatedUsefuleLifeOfAssetsTableTextBock_zXzlcO38DgT8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets are stated at cost less accumulated depreciation and are being depreciated using the straight-line method over the estimated useful life of the asset as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zPFPpKksaOVf" style="display: none">Schedule of Estimated Usefule Life of Assets</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 84%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RAS System</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RASSystemMember_zYI833SLLpW4" title="Property plant and equipment useful life">10</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_z2cYeFoj3926" title="Property plant and equipment useful life">7</span> to <span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_z0FN3u0ZO08e" title="Property plant and equipment useful life">10</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zdKSG2v3ASEh" title="Property plant and equipment useful life">5</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse and refrigeration equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseAndRefrigerationEquipmentMember_zTDiGApbRV4j" title="Property plant and equipment useful life">10</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zXvLp8ghv3E7" title="Property plant and equipment useful life">7</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Automobile</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--AutomobileMember_zo5ewaPWSvX" title="Property plant and equipment useful life">5</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade show booth</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeShowBoothMember_zKLEJdhhfFUb" title="Property plant and equipment useful life">7</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table>
CY2023 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2022 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
1873619 usd
CY2023 us-gaap Foreign Currency Translation Adjustment Description
ForeignCurrencyTranslationAdjustmentDescription
The rate used in the financial statements for TOBC as presented for December 31, 2023 was 0.74 Canadian Dollars to U.S. Dollars and for December 31, 2022 was 0.80 Canadian Dollars to U.S. Dollars
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
55900 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
60100 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
125014 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
35428 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
89586 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
72526 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.073 pure
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
44456 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
44456 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
44456 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
11117 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
144485 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
19471 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
125014 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
35428 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
89586 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
4500 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
5400 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zPnSPCnSOou8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_z4I6ntjDE8aj">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zYX1AUyH2aC1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zBKwNH3SI1Nk">Customer Concentration</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had sixteen customers which accounted for approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SixteenCustomerMember_zsJAxhCvwf6l" title="Concentration risk percentage">52</span>% of revenue during the year ended December 31, 2023. Two customers accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomerMember_zAD967ABrqoc" title="Revenue">22</span>% of revenue during the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had nine customers which accounted for approximately <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TenCustomerMember_z3F7z8WmLPpc" title="Concentration risk percentage">59</span>% of revenue during the year ended December 31, 2022. One customer accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zmoGgDQf7Llk" title="Revenue">36</span>% of revenue during the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The loss of any major customer could have a material adverse impact on the Company’s results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
1047049 usd
CY2023Q4 BSFC Fair Value Net Warrant Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetWarrantAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
1574 usd
CY2023Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
1048623 usd
CY2023Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
383672 usd
CY2023Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
663377 usd
CY2023Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
1047049 usd
CY2023Q4 BSFC Fair Value Net Warrant Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetWarrantAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
5032025 usd
CY2023Q4 BSFC Fair Value Net Warrant Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease
FairValueNetWarrantAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
-3160465 usd
CY2023Q4 BSFC Fair Value Net Warrant Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetWarrantAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
1574 usd
CY2023 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
316540 usd
CY2022 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
223076 usd
CY2023 BSFC Amount Of Dilutive Securities Stock Warrant And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockWarrantAndRestrictiveStockUnits
730944 usd
CY2022 BSFC Amount Of Dilutive Securities Stock Warrant And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockWarrantAndRestrictiveStockUnits
120675 usd
CY2023 us-gaap Amount Of Dilutive Securities Esop Convertible Preferred Stock
AmountOfDilutiveSecuritiesESOPConvertiblePreferredStock
11708483 usd
CY2023 us-gaap Dilutive Securities
DilutiveSecurities
12755967 usd
CY2022 us-gaap Dilutive Securities
DilutiveSecurities
343751 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33810732 usd
CY2023Q4 BSFC Working Capital Deficit
WorkingCapitalDeficit
899215 usd
CY2023Q4 us-gaap Subordinated Debt
SubordinatedDebt
165620 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
83000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
67000 usd
CY2023 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2022 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4471612 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
833472 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
671933 usd
CY2023Q4 us-gaap Retainage Deposit
RetainageDeposit
136000 usd
CY2023Q4 BSFC Prepaid Legal Fees
PrepaidLegalFees
158000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
342679 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2399303 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38822 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2278903 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
303857 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120400 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4500 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
231000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3497806 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-3497806 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
315000 usd
CY2023Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
2.40
CY2023Q4 us-gaap Share Price
SharePrice
1000.00
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23086077 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23086077 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1338321 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1338321 shares
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
23705 shares
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
182982 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
69125 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
187385 usd
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.20 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
51514 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
0.35
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.35 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.45 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.39 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.48 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0287 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0472 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0287 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0427 pure
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
221484 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
40.00
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M23D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10412 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
36.40
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
46.00
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
206082 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
223076 shares
CY2022Q4 BSFC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
40.00 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
206082 shares
CY2022Q4 BSFC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
40.00 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M10D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
94714 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.58
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1250 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
40.00
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
219908 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
316540 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.11
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
219908 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
31.11
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y3M7D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
96632 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
16994 shares
CY2023 BSFC Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Exercisable Weighted Average Remaining Contractual Term1
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingExercisableWeightedAverageRemainingContractualTerm1
P5Y6M7D
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
851925 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2770944 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-206832 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0510 pure
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-309886 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0235 pure
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-237419 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.0585 pure
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
10621 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.00048 pure
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
74848 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.0185 pure
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2751592 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2085 pure
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1221327 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.3011 pure
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
318617 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0242 pure
CY2022Q4 BSFC Deferred Tax Assets Business Interest Limitation
DeferredTaxAssetsBusinessInterestLimitation
627930 usd
CY2023Q4 BSFC Deferred Tax Assets Allowance For Bad Debt
DeferredTaxAssetsAllowanceForBadDebt
5797 usd
CY2023Q4 BSFC Deferred Tax Assets Fixed Assets
DeferredTaxAssetsFixedAssets
136208 usd
CY2022Q4 BSFC Deferred Tax Assets Fixed Assets
DeferredTaxAssetsFixedAssets
140494 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1017629 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
3626165 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
2089409 usd
CY2023Q4 BSFC Noncapital Losses
NoncapitalLosses
511340 usd
CY2022Q4 BSFC Noncapital Losses
NoncapitalLosses
365053 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
83687 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
46385 usd
CY2023Q4 BSFC Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
4363197 usd
CY2022Q4 BSFC Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
4286900 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4363197 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4286900 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1500 usd
CY2023 us-gaap Payments For Rent
PaymentsForRent
166000 usd
CY2022 us-gaap Payments For Rent
PaymentsForRent
168000 usd

Files In Submission

Name View Source Status
0001493152-24-012503-index-headers.html Edgar Link pending
0001493152-24-012503-index.html Edgar Link pending
0001493152-24-012503.txt Edgar Link pending
0001493152-24-012503-xbrl.zip Edgar Link pending
bsfc-20231231.xsd Edgar Link pending
ex10-71.htm Edgar Link pending
ex10-71_001.jpg Edgar Link pending
ex10-72.htm Edgar Link pending
ex10-72_001.jpg Edgar Link pending
ex10-72_002.jpg Edgar Link pending
ex10-72_003.jpg Edgar Link pending
ex10-72_004.jpg Edgar Link pending
ex10-72_005.jpg Edgar Link pending
ex10-72_006.jpg Edgar Link pending
ex10-72_007.jpg Edgar Link pending
ex10-72_008.jpg Edgar Link pending
ex10-73.htm Edgar Link pending
ex10-74.htm Edgar Link pending
ex31-1.htm Edgar Link pending
bsfc-20231231_cal.xml Edgar Link unprocessable
bsfc-20231231_def.xml Edgar Link unprocessable
bsfc-20231231_pre.xml Edgar Link unprocessable
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-6.htm Edgar Link pending
ex97.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
form10-k_002.jpg Edgar Link pending
form10-k_003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
form10-k_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bsfc-20231231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable